PlainRecalls
FDA Drug Low Class III Terminated

Amiodarone Hydrochloride Injection, USP, 450 mg per 9 mL (50 mg / mL), 9 mL Single Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-181-09

Reported: December 4, 2019 Initiated: November 11, 2019 #D-0521-2020

Product Description

Amiodarone Hydrochloride Injection, USP, 450 mg per 9 mL (50 mg / mL), 9 mL Single Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-181-09

Reason for Recall

Crystallization: Presence of visible particulate matter.

Details

Recalling Firm
AuroMedics Pharma LLC
Units Affected
29,830 vials
Distribution
Distributed Nationwide in the US
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Amiodarone Hydrochloride Injection, USP, 450 mg per 9 mL (50 mg / mL), 9 mL Single Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-181-09. Recalled by AuroMedics Pharma LLC. Units affected: 29,830 vials.
Why was this product recalled?
Crystallization: Presence of visible particulate matter.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 4, 2019. Severity: Low. Recall number: D-0521-2020.